Beatrice U. Mueller

5.1k total citations · 1 hit paper
64 papers, 3.7k citations indexed

About

Beatrice U. Mueller is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Beatrice U. Mueller has authored 64 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 32 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Beatrice U. Mueller's work include Acute Myeloid Leukemia Research (33 papers), Multiple Myeloma Research and Treatments (11 papers) and Retinoids in leukemia and cellular processes (10 papers). Beatrice U. Mueller is often cited by papers focused on Acute Myeloid Leukemia Research (33 papers), Multiple Myeloma Research and Treatments (11 papers) and Retinoids in leukemia and cellular processes (10 papers). Beatrice U. Mueller collaborates with scholars based in Switzerland, United States and Germany. Beatrice U. Mueller's co-authors include Thomas Pabst, Thomas Pabst, Daniel G. Tenen, Gerhard Behre, Wolfgang Hiddemann, Pu Zhang, Sailaja Narravula, Marianne Eyholzer, Hanna S. Radomska and Susanne Schnittger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Genetics.

In The Last Decade

Beatrice U. Mueller

64 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia

2001 681 citations Thomas Pabst, Beatrice U. Mueller et al. profile →

Peers

Countries citing papers authored by Beatrice U. Mueller

Since Specialization

Citations

This map shows the geographic impact of Beatrice U. Mueller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatrice U. Mueller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatrice U. Mueller more than expected).

Fields of papers citing papers by Beatrice U. Mueller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatrice U. Mueller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatrice U. Mueller. The network helps show where Beatrice U. Mueller may publish in the future.

Co-authorship network of co-authors of Beatrice U. Mueller

This figure shows the co-authorship network connecting the top 25 collaborators of Beatrice U. Mueller. A scholar is included among the top collaborators of Beatrice U. Mueller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beatrice U. Mueller. Beatrice U. Mueller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comorbidities Associated with Worse Outcomes Among Inpatients Admitted for Acute Gastrointestinal Bleeding 2021 ·Digestive Diseases and Sciences ·(unknown), J. Blaser, Albina Nowak, Marcus Cheetham, Beatrice U. Mueller, Edouard Battegay, Patrick E. Beeler	10
2	The maximum alcohol withdrawal syndrome score associates with worse clinical outcomes—A retrospective cohort study 2019 ·Drug and Alcohol Dependence ·(unknown), Beatrice U. Mueller, Edouard Battegay, Patrick E. Beeler	1
3	Autologous Transplantation for Older Adults with AML 2018 ·Cancers ·Beatrice U. Mueller, Katja Seipel, Ulrike Bacher, Thomas Pabst	18
4	Myelodysplastic syndromes and acute myeloid leukemias in the elderly 2018 ·European Journal of Internal Medicine ·Beatrice U. Mueller, Katja Seipel, Thomas Pabst	3
5	MDM2- and FLT3-inhibitors in the treatment of FLT3-ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurin 2018 ·Haematologica ·Katja Seipel, (unknown), Corinne Sidler, Beatrice U. Mueller, Thomas Pabst	35
6	NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma 2017 ·Bone Marrow Transplantation ·(unknown), Urban Novak, Behrouz Mansouri Taleghani, Gabriela M. Baerlocher, Katja Seipel, Beatrice U. Mueller, (unknown), Daniel Betticher, (unknown), Stefan Farese, (unknown), Thomas Pabst	11
7	Inactivation of the p53–KLF4–CEBPA Axis in Acute Myeloid Leukemia 2015 ·Clinical Cancer Research ·Katja Seipel, (unknown), (unknown), (unknown), Beatrice U. Mueller, Thomas Pabst	41
8	Consolidation of first remission using radioimmunotherapy with yttrium-90-ibritumomab-tiuxetan in adult patients with Burkitt lymphoma 2015 ·Leukemia Research ·(unknown), Bernd Klaeser, Yara Banz, Beatrice U. Mueller, Thomas Pabst	4
9	CD34+ selected versus unselected autologous stem cell transplantation in patients with advanced-stage mantle cell and diffuse large B-cell lymphoma 2015 ·Leukemia Research ·Martin D. Berger, (unknown), Kurt Leibundgut, Gabriela M. Baerlocher, Katja Seipel, Beatrice U. Mueller, Michael Gregor, (unknown), Thomas Pabst	8
10	Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatment 2015 ·Leukemia Research ·Sandra Keller, Katja Seipel, Urban Novak, Beatrice U. Mueller, Behrouz Mansouri Taleghani, Kurt Leibundgut, Thomas Pabst	15
11	Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicity 2015 ·Leukemia & lymphoma ·Beatrice U. Mueller, Sandra Keller, Katja Seipel, Behrouz Mansouri Taleghani, Daniel Rauch, Daniel Betticher, Thomas Egger, Thomas Pabst	8
12	Role of plerixafor in autologous stem cell mobilization with vinorelbine chemotherapy and granulocyte-colony stimulating factor in patients with myeloma: a phase II study (PAV-trial) 2014 ·Leukemia & lymphoma ·(unknown), (unknown), Behrouz Mansouri Taleghani, Peter M. Keller, Beatrice U. Mueller, Gabriela M. Baerlocher, Kurt Leibundgut, Thomas Pabst	14
13	Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemia 2014 ·British Journal of Haematology ·Dana L. Wetzel, Beatrice U. Mueller, Behrouz Mansouri Taleghani, Gabriela M. Baerlocher, Katja Seipel, Kurt Leibundgut, Thomas Pabst	12
14	Activation of the Unfolded Protein Response in Human Acute Myeloid Leukemia 2011 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Julian Schardt, Beatrice U. Mueller, Thomas Pabst	21
15	PU.1 is regulated by NF-κB through a novel binding site in a 17 kb upstream enhancer element 2009 ·Oncogene ·Nicolas Bonadies, (unknown), Andreas Steege, Subrahmanya Vallabhapurapu, Thomas Pabst, Beatrice U. Mueller	33
16	Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis 2009 ·British Journal of Cancer ·Thomas Pabst, Marianne Eyholzer, (unknown), Beatrice U. Mueller	116
17	Lineage-Specific Transcription Factor Aberrations in AML 2009 ·Cancer treatment and research ·Beatrice U. Mueller, Thomas Pabst	1
18	Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia 2009 ·Journal of Cellular and Molecular Medicine ·Julian Schardt, Marianne Eyholzer, Nikolai A. Timchenko, Beatrice U. Mueller, Thomas Pabst	30
19	AML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia 2001 ·Nature Medicine ·Thomas Pabst, Beatrice U. Mueller, Nari Harakawa, Claudia Schoch, Torsten Haferlach, Gerhard Behre, Wolfgang Hiddemann, D E Zhang, Daniel G. Tenen	375
20	Regulation of Endothelial CD73 by Adenosine: Paracrine Pathway for Enhanced Endothelial Barrier Function 2000 ·The Journal of Immunology ·Sailaja Narravula, Paul Lennon, Beatrice U. Mueller, Sean P. Colgan	101

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact